ع
Sections
  • Politics
  • Culture & Social Affairs
  • Business & Economy
  • Science & Technology
  • Documents & Memoirs
Regions
  • Gulf
  • MENA
  • Europe
  • USA
  • Asia
  • World
More
  • Videos
  • Cartoons
  • World in photos
  • Infographics
  • Profiles
  • Newsletter

LATEST ISSUE

Latest Issue
Magazine Archive
النسخة العربية
  • Politics
  • Culture & Social Affairs
  • Business & Economy
  • Science & Technology
  • Tag
  • BioNTech

Vials with a sticker reading, "COVID-19 / Coronavirus vaccine / Injection only" and a medical syringe are seen in front of a displayed Pfizer logo in this illustration taken October 31, 2020. REUTERS/Dado Ruvic/File Photo

U.S. FDA, CDC See Early Signal of Possible Pfizer Bivalent COVID Shot Link to Stroke

A safety monitoring system flagged that U.S. drugmaker Pfizer Inc (PFE.N) and German partner BioNTech's updated COVID-19 shot could be linked to a type of brain stroke in older adults, according to…

15 January 2023
A vial of the Pfizer-BioNTech coronavirus disease (COVID-19) booster vaccine targeting BA.4 and BA.5 Omicron sub variants is pictured at Skippack Pharmacy in Schwenksville, Pennsylvania, U.S., September 8, 2022. REUTERS/Hannah Beier/File Photo

Pfizer/BioNTech Seek FDA Nod For New COVID Boosters For Children

Pfizer Inc (PFE.N) and its German partner BioNTech on Monday sought the U.S. Food and Drug Administration's authorization for an Omicron-tailored COVID-19 vaccine booster for children aged 5 through…

26 September 2022
A healthcare worker prepares to administer a Pfizer/BioNTEch coronavirus disease (Covid-19) vaccine at The Michener Institute, in Toronto, Ontario on December 14, 2020. - Ontario, Canada's most populous province and one of the hardest hit by the pandemic, had 1,940 new cases and 23 deaths on Monday. The province is expected to give its next doses to nursing home workers as a priority, according to media reports. (Photo by CARLOS OSORIO / POOL / AFP) (Photo by CARLOS OSORIO/POOL/AFP via Getty Images)

Here’s Why the FDA Shouldn’t Rush Giving Full Approval to the COVID Vaccines

It’s undoubtedly a coincidence, but two commentators I find most thoughtful and trustworthy both weighed in Wednesday on the question of whether the Food and Drug Administration should just go ahead…

Michael Hiltzik 25 July 2021
  • Popular
  • Editor's Pick
Gregori Saavedra
Politics

Syria takes on Iran’s proxies

12, Nov 2026

Our cover story this week explores the opportunities and risks accompanying Syria's shift from being a corridor of Iranian influence to a state intent on containing it

Baghdad, London - Al Majalla
Al Majalla
Business & Economy

Jensen Huang is out. His successor has the toughest job in tech

13, Nov 2026

A company built around one man must now learn to run without him

The Economist
Eduardo Ramon
Politics

Why the midterms complicate Trump's search for an Iran deal

14, Nov 2026

Democratic control of Congress will increase scrutiny of the war and its economic costs, but could also make the concessions needed for a lasting agreement with Tehran more difficult to deliver

Neil Quilliam and Alice Gower
Ibrahim Arafath
Science & Technology

AI in medicine: can a selfie tell how long we might live?

15, Nov 2026

Artificial intelligence can analyse facial features for clues to biological ageing and cancer survival, but further validation is needed before clinical use

Alaa Emara
Nash
Politics

The Democrats’ old guard faces a progressive revolt 

15, Nov 2026

Following an historic landslide, a new progressive wave is calling for establishment figures to step aside and make way for new blood who better represent the future direction of the party

Tarek Rashed

Sign up for the Weekly Newsletter

Get the best of Al Majalla, straight to your inbox.

Your newsletter subscriptions are subject to Al Majalla privacy policy and terms and conditions.

OPINIONS

Kurdistan: allies come and go, neighbours remain

Ibrahim Hamidi
Ibrahim Hamidi

The Democrats’ old guard faces a progressive revolt 

Tarek Rashed
Tarek Rashed

AI in medicine: can a selfie tell how long we might live?

Alaa Emara

Libya’s economy: so much potential, so many problems

Rifaat Balkhair
Rifaat Balkhair
MORE FROM OPINIONS
logo
  • Politics
  • Culture & Social Affairs
  • Business & Economy
  • Science & Technology
  • Documents & Memoirs
  • Gulf
  • MENA
  • Europe
  • USA
  • Asia
  • World
  • Videos
  • Cartoons
  • World in photos
  • Infographics
  • Profiles
  • About Al Majalla
  • Al Majalla Team
  • Terms of Service
  • Privacy Policy
  • Contact us
logo

© Al Majalla Magazine. All Rights Reserved.

0:00:00
0:00:00